Intervention

Exendin (9-39)

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions5

Lead sponsors shown4

Clinical trials

4 shown

Regulation of Insulin Secretion by the GLP-1 ReceptorNCT02844907 · 2018-07-01

Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small IntestinesNCT03241303 · 2017-08-01

Cardiovascular Effects of GLP-1 Receptor ActivationNCT03101930 · 2017-05-01

Ghrelin Effect on Beta Cell Function in Health and DiseaseNCT01729299 · 2013-04-01

Common conditions

Diabetes1 Glucose Metabolism Disorders1 Insulin Secretion1 Obesity1 PreDiabetes1

Leading sponsors

David Dalessio1 University Hospital, Gentofte, Copenhagen1 VA Office of Research and Development1 Vanderbilt University Medical Center1

Trial status mix

COMPLETED2

TERMINATED1

UNKNOWN1

Phase mix

NA2

PHASE42

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.